Vijaya Diagnostic Centre Limited
NSE:VIJAYA.NS
1119.45 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,562.168 | 1,552.052 | 1,326.916 | 1,388.589 | 1,210.496 | 1,209.928 | 1,131.185 | 1,207.493 | 1,043.621 | 1,159.432 | 1,107.758 | 1,127.073 | 1,225.89 | 1,117.165 | 998.83 | 1,131.438 | 517.02 |
| Cost of Revenue
| 627.497 | 596.334 | 159.88 | 163.484 | 142.876 | 155.3 | 136.653 | 166.535 | 130.328 | 178.776 | 162.989 | 162.385 | 210.84 | 162.653 | 139.777 | 192.973 | 75.54 |
| Gross Profit
| 934.671 | 955.718 | 1,167.036 | 1,225.105 | 1,067.62 | 1,054.628 | 994.532 | 1,040.958 | 913.293 | 980.656 | 944.769 | 964.688 | 1,015.05 | 954.512 | 859.053 | 938.465 | 441.48 |
| Gross Profit Ratio
| 0.598 | 0.616 | 0.88 | 0.882 | 0.882 | 0.872 | 0.879 | 0.862 | 0.875 | 0.846 | 0.853 | 0.856 | 0.828 | 0.854 | 0.86 | 0.829 | 0.854 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 310.943 | 0 | 0 | 0 | 266.61 | 0 | 0 | 151.11 | 161.682 | 0 | 0 | 69.16 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 57.353 | 0 | 0 | 0 | 46.078 | 0 | 0 | 7.86 | 31.448 | 0 | 0 | 5.92 |
| SG&A
| 488.641 | 487.595 | 413.697 | 433.259 | 208.493 | 368.296 | 354.344 | 356.123 | 319.601 | 312.688 | 284.257 | 282.257 | 158.97 | 193.13 | 151.765 | 142.293 | 75.08 |
| Other Expenses
| 35.64 | 32.503 | 51.1 | 67.51 | 57.067 | 45.189 | 35.582 | 33.043 | 27.693 | -91.224 | 32.015 | 31.545 | 0.56 | -60.806 | 29.91 | 23.659 | 0.09 |
| Operating Expenses
| 488.641 | 487.595 | 789.391 | 788.33 | 711.136 | 677.122 | 754.525 | 712.572 | 656.12 | 654.834 | 596.544 | 577.981 | 565.71 | 529.915 | 519.836 | 563.177 | 419.42 |
| Operating Income
| 446.03 | 468.123 | 428.745 | 504.285 | 356.484 | 422.695 | 275.589 | 361.429 | 257.173 | 325.759 | 348.225 | 386.707 | 449.34 | 443.391 | 369.127 | 398.947 | 22.06 |
| Operating Income Ratio
| 0.286 | 0.302 | 0.323 | 0.363 | 0.294 | 0.349 | 0.244 | 0.299 | 0.246 | 0.281 | 0.314 | 0.343 | 0.367 | 0.397 | 0.37 | 0.353 | 0.043 |
| Total Other Income Expenses Net
| -27.011 | -29.438 | -81.107 | -58.525 | -1.758 | -57.686 | -55.403 | -48.739 | -19.958 | -11.442 | -9.743 | -7.823 | -7.19 | -17.321 | -36.012 | -43.356 | -15.58 |
| Income Before Tax
| 419.019 | 438.685 | 347.638 | 445.76 | 354.726 | 365.009 | 220.186 | 312.69 | 237.215 | 314.317 | 338.482 | 378.884 | 442.15 | 426.07 | 333.115 | 355.591 | 6.48 |
| Income Before Tax Ratio
| 0.268 | 0.283 | 0.262 | 0.321 | 0.293 | 0.302 | 0.195 | 0.259 | 0.227 | 0.271 | 0.306 | 0.336 | 0.361 | 0.381 | 0.334 | 0.314 | 0.013 |
| Income Tax Expense
| 103.967 | 101.909 | 87.626 | 110.023 | 90.88 | 87.742 | 55.625 | 78.018 | 61.645 | 75.481 | 83.872 | 98.915 | 108.9 | 111.401 | 82.642 | 89.705 | -11.62 |
| Net Income
| 313.452 | 334.509 | 258.487 | 333.22 | 262.037 | 274.928 | 163.636 | 233.252 | 174.5 | 237.125 | 252.865 | 277.119 | 329.69 | 312.01 | 247.276 | 264.231 | 19.13 |
| Net Income Ratio
| 0.201 | 0.216 | 0.195 | 0.24 | 0.216 | 0.227 | 0.145 | 0.193 | 0.167 | 0.205 | 0.228 | 0.246 | 0.269 | 0.279 | 0.248 | 0.234 | 0.037 |
| EPS
| 3.06 | 3.27 | 2.53 | 3.26 | 2.57 | 2.69 | 1.6 | 2.29 | 1.71 | 2.33 | 2.48 | 2.72 | 3.23 | 3.08 | 2.43 | 2.59 | 0.19 |
| EPS Diluted
| 3.05 | 3.26 | 2.52 | 3.25 | 2.57 | 2.68 | 1.6 | 2.27 | 1.7 | 2.32 | 2.46 | 2.7 | 3.23 | 3.08 | 2.42 | 2.59 | 0.19 |
| EBITDA
| 612.37 | 631.096 | 574.155 | 641.164 | 538.251 | 536.257 | 478.438 | 520.46 | 426.625 | 498.12 | 510.312 | 543.026 | 593.04 | 568.899 | 494.161 | 536.585 | 157.37 |
| EBITDA Ratio
| 0.392 | 0.407 | 0.433 | 0.462 | 0.445 | 0.443 | 0.423 | 0.431 | 0.409 | 0.43 | 0.461 | 0.482 | 0.484 | 0.509 | 0.495 | 0.474 | 0.304 |